PAFAH1B3 predicts poor prognosis and promotes progression in lung adenocarcinoma

Suping Tang; Jun Ni; Bohua Chen; Fei Sun; Jinbo Huang; Songshi Ni; Zhiyuan Tang

doi:10.1186/s12885-022-09617-x

ScienceGate Book Chapters

JOURNAL ARTICLE

PAFAH1B3 predicts poor prognosis and promotes progression in lung adenocarcinoma

Suping Tang Jun Ni Bohua Chen Fei Sun Jinbo Huang Songshi Ni Zhiyuan Tang

Year: 2022 Journal: BMC Cancer Vol: 22 (1)Pages: 525-525 Publisher: BioMed Central

DOI: 10.1186/s12885-022-09617-x

Get Full-Text PDF Get Analytical Report

Keywords:

Immunohistochemistry Cancer research Cell cycle Biology Adenocarcinoma Flow cytometry Gene silencing Cell growth Population Metastasis Cell Pathology Oncology Medicine Immunology Internal medicine Cancer Gene

Metrics

Cited By

1.48

FWCI (Field Weighted Citation Impact)

Refs

0.74

Citation Normalized Percentile

Is in top 1%

Is in top 10%

Citation History

Topics

Cancer-related gene regulation

Life Sciences → Biochemistry, Genetics and Molecular Biology → Molecular Biology

Ferroptosis and cancer prognosis

Health Sciences → Medicine → Pulmonary and Respiratory Medicine

Epigenetics and DNA Methylation

Life Sciences → Biochemistry, Genetics and Molecular Biology → Molecular Biology

PAFAH1B3 predicts poor prognosis and promotes progression in lung adenocarcinoma

Metrics

Citation History

Topics

Related Documents

Additional file 1 of PAFAH1B3 predicts poor prognosis and promotes progression in lung adenocarcinoma

Additional file 1 of PAFAH1B3 predicts poor prognosis and promotes progression in lung adenocarcinoma

TOP2A Promotes Lung Adenocarcinoma Cells' Malignant Progression and Predicts Poor Prognosis in Lung Adenocarcinoma

Upregulation of POC1A in lung adenocarcinoma promotes tumour progression and predicts poor prognosis

CA916798 predicts poor prognosis and promotes Gefitinib resistance for lung adenocarcinoma